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ABSTRACT The four-a-helix bundle mimics the transmembrane domain of the Cys-loop receptor family believed to be the
protein target for general anesthetics. Using high resolution NMR, we solved the structure (Protein Data Bank ID: 2I7U) of a
prototypical dimeric four-a-helix bundle, (Aa2-L1M/L38M)2, with designed speciﬁc binding pockets for volatile anesthetics. Two
monomers of the helix-turn-helix motif form an antiparallel dimer as originally designed, but the high-resolution structure exhibits
an asymmetric quaternary arrangement of the four helices. The two helices from the N-terminus to the linker (helices 1 and 19)
are associated with each other in the dimer by the side-chain ring stacking of F12 and W15 along the long hydrophobic core and
by a nearly perfect stretch of hydrophobic interactions between the complementary pairs of L4, L11, L18, and L25, all of which
are located at the heptad e position along the helix-helix dimer interface. In comparison, the axes of the two helices from the
linker to the C-terminus (helices 2 and 29) are wider apart from each other, creating a lateral access pathway around K47 from
the aqueous phase to the center of the designed hydrophobic core. The site of the L38M mutation, which was previously shown
to increase the halothane binding afﬁnity by ;3.5-fold, is not part of the hydrophobic core presumably involved in the anesthetic
binding but shows an elevated transverse relaxation (R2) rate. Qualitative analysis of the protein dynamics by reduced spectral
density mapping revealed exchange contributions to the relaxation at many residues in the helices. This observation was
conﬁrmed by the quantitative analysis using the Modelfree approach and by the NMR relaxation dispersion measurements. The
NMR structures and Autodock analysis suggest that the pocket with the most favorable amphipathic property for anesthetic
binding is located between the W15 side chains at the center of the dimeric hydrophobic core, with the possibility of two
additional minor binding sites between the F12 and F52 ring stacks of each monomer. The high-resolution structure of the
designed anesthetic-binding protein offers unprecedented atomistic details about possible sites for anesthetic-protein interac-
tions that are essential to the understanding of molecular mechanisms of general anesthesia.
INTRODUCTION
Recent mutagenesis and biophysics investigations have led to
the belief that general anesthetics, although structurally di-
verse, can interact with proteins in a speciﬁc manner (1–7).
Among the proteins that are essential for neurological func-
tions, a superfamily of neurotransmitter-gated postsynaptic
receptors, known as the Cys-loop receptors, has been shown
to be particularly sensitive to volatile anesthetics (8). The
Cys-loop receptors are ion channels that, on activation by
neurotransmitter binding, respond to fast synaptic transmis-
sions in the central and peripheral nervous systems (9). These
ion channels are formed by association of ﬁve subunits, each
of which has four transmembrane (TM) domains, traversing
the membrane four times as a four-a-helix bundle. Point
mutations in the TM domains of the Cys-loop receptors have
been found to signiﬁcantly alter the receptors’ sensitivity to
volatile anesthetics (10), implicating certain speciﬁc inter-
actions between the anesthetics and the TM four-a-helix
bundles.
Despite numerous functional investigations, the current
knowledge on the structure-function relationship of anes-
thetic-protein interactions is limited. This is largely because
of the technical difﬁculties in studying membrane proteins.
Although signiﬁcant progress has been made in recent years
(11–17), no structure at the atomistic resolution is currently
available for the four-a-helix bundle TM domains of the Cys-
loop receptors.
To understand the structural basis of anesthetic-protein
interactions, de novo designs of prototype four-a-helix bun-
dles with speciﬁc anesthetic binding pockets have been pro-
posed (18,19). The original design, denoted as (La2)2, was
composed of a Leu-rich hydrophobic core as part of an an-
esthetic binding pocket. The pocket was later modiﬁed with
six Leu-to-Ala mutations (denoted as (Aa2)2), leading to a
factor of 4.4 improvement in the halothane binding afﬁnity.
Further optimization with an additional 3.5-fold binding af-
ﬁnity increase was achieved in (Aa2)2 with the L38M point
mutation (19). This newer generation four-a-helix bundle
protein has a halothane dissociation constant, Kd, of 0.2 mM,
which is essentially the same as the clinical concentration for
halothane. Thus, (Aa2-L38M)2 is considered one of the most
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suitable models for the volatile anesthetic binding targets in
the four-a-helix bundle scaffold proteins.
Because of the size difference between the Leu and Ala
side chains, the improvement in anesthetic binding due to the
Leu-to-Ala mutations in (Aa2)2 was interpreted intuitively as
the result of the steric effects, namely, a possibly better ﬁt
between anesthetic molecules and their binding pockets.
Nearly the same degree of improvement seen in the L38M
mutation, however, was not expected fully by design. Mo-
lecular dynamics simulations of a structure model for (Aa2-
L38M)2 showed thatM38was not even part of the hydrophobic
core (20), suggesting that factors other than simple geometric
ﬁtting or steric restrictions between anesthetic molecules and
protein pockets might be at play in determining the anesthetic
binding afﬁnity. To better understand these factors, we de-
termined the high-resolution structure and dynamics of the
bacterial-expressed (Aa2-L1M/L38M)2, which has compat-
ible anesthetic-binding properties to the early chemically
synthesized (Aa2-L38M)2 (21). The sequence of this 62-
residue peptide and the heptad repeat assignments used to
design the amphiphilic a-helices are shown in Fig. 1. We
present here the results of our investigation in the absence of
any anesthetic binding and emphasize the intrinsic structural
and dynamical properties of this designed anesthetic-binding
protein. The parallel studies of the same protein in the pres-
ence of halothane are presented in our Part II article in this
issue (22).
MATERIALS AND METHODS
Sample preparation
(Aa2-L1M/L38M)2 was expressed using BL21 codon plus (DE3)-RP com-
petent Escherichia coli cells in M9 minimal media and puriﬁed using re-
versed-phase HPLC, as described previously (21). The L1M mutation was
required for the bacteria to express the protein without a fusion protein. The
M9medium contained (15NH4)2SO4 and
13C-glucose as the sole 15N and 13C
sources for uniform 15N and 13C labeling, respectively. The puriﬁed protein
was lyophilized and stored at –20C until use. NMR samples were prepared
by dissolving lyophilized protein in a 10% D2O/90% H2O solution to a
monomer concentration of 0.5 mM in a total volume of 300–400 mL. Ap-
proximately 1 mL of 100 mM 2,2-dimethyl-2-silapentane-5-sulfonate (DSS)
sodium salt was added as an internal chemical shift reference. Typically, the
unbuffered sample has a pH of 4.5. Samples prepared in this way have been
stable for several months if stored at 4C.
NMR experiments
A suite of two-dimensional and three-dimensional (3D) NMR experiments
for spectral assignment, including 1H-15N HSQC, HNCO, HNCA,
HN(CO)CA, HNCACB, CBCA(CO)NH, HBHANH, and HBHA(CO)NH,
was performed at 35C using a Bruker Avance 600 MHz spectrometer
equipped with a cryoprobe (Bruker Instruments, Billerica, MA). The 13C-
decoupled 1H-15N HSQC was acquired in 1024 (1H) 3 128 (15N) complex
points, with a spectral width of 10 ppm for 1H and 23 ppm for 15N, and
averaged for 16 scans. TheHNCACBwas acquired in 512 (1H)3 24 (15N)3
64 (13C) complex points, with spectral widths of 10 ppm (1H), 22 ppm (15N),
and 64 ppm (13C), and 32 scans. The CBCA(CO)NH, HNCO, HNCA, and
HN(CO)CA were each acquired in 512 (1H)3 30 (15N)3 64 (13C) complex
points, with spectral widths of 10 ppm (1H) and 22 ppm (15N), and 16 scans.
The 13C spectral widths were 64 ppm (CBCA(CO)NH), 20 ppm (HNCO and
HNCA), or 24 ppm (HN(CO)CA).
The 3D HCCH-TOCSY was acquired at 35C on a Bruker Avance 700
MHz spectrometer with a cryoprobe using the following parameters:
1024(1H)3 64(13C)3128(1H-indirect) points, spectral widths of 10 ppm for
1H and 75 ppm for 13C, carrier at H2O resonance for
1H and 41.65 ppm for
13C, and 16 transients for each time increment. To assist with manual as-
signments and to obtain distance constraints for the structure calculation,
15N-edited 3D NOESY (mixing time of 120 ms and 150 ms) and 13C-edited
3D NOESY (mixing time of 75 ms and 150 ms) were performed. All four
NOESY experiments had 512 (1H) 3 30 (15N) 3 64 (13C) complex points
and 16 scans. The spectral widths were 10 ppm for 1H, 22 PM for 15N, and 40
ppm for 13C.
To measure the temperature effects, a series of 1H-15N HSQC experi-
ments were performed at 25, 30, 35, and 40C. The same sample as the one
for the assignment experiments was used. The experiments were performed
on a Bruker Avance 600MHz spectrometer with a TXI probe. At least 30min
were given between each temperature change for the sample to equilibrate
before proceeding with the experiment. HSQC at 35Cwas repeated to verify
that the protein had not irreversibly changed at different temperature steps.
Each 1H-15N HSQC was acquired with 16 scans in 512 (1H) 3 64 (15N)
complex points and spectral widths of 10 ppm (1H) and 22 ppm (15N).
The four-a-helix bundle dynamics was measured at 35C using 15N R1
and R2 relaxation and
15N-{1H} heteronuclear NOE experiments. A Bruker
FIGURE 1 (A) The primary structure of (Aa2-L1M/L38M)2 four-a-helix
bundle protein with the heptad position a and d positions highlighted in
boldface. (B) Wheel diagram showing a single cycle of the heptad repeat.
The left two helices belong to a monomer (gray) with the linker below the
plane of the page, and the right two helices belong to another monomer
(black) with the linker above the plane of the page. The direction of the
helices is indicated by the1 and – signs. The a and d positions on the helices
form the hydrophobic core of the four-a-helix bundle.
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Avance 600 MHz spectrometer with a TXI probe and the Bruker standard
pulse sequences were used. In the R2 measurements, the interpulse delay
between two adjacent 15N 180 pulses in the CPMG sequence was 1000 ms
(including a 100-ms pulse width), and thus the ﬁeld strength of the CPMG
refocusing pulses was 1.0 kHz. 512 (1H) 3 128 (15N) complex points were
taken, interleaving with and without 1H saturation. The spectral widths were
10 ppm for 1H and 22 ppm for 15N, with 88 scans for hetNOE and 24 scans
for R1 and R2 measurements. The R1 was determined using 8 delay values:
20, 50, 100, 200, 400, 600, 1100, 2000 ms. The R2 experiments used eight
delay values: 17, 34, 51, 68, 85, 119, 153, 221 ms. The relaxation rate
constants were obtained by exponential ﬁtting. The hetNOE values were
deﬁned as the ratios of peak intensities with and without proton saturation.
The uncertainties of hetNOE values, DNOE, were calculated using the well-
established method (23):
DNOE
NOE
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DIsat
Isat
 2
1
DIunsat
Iunsat
 2s
; (1)
where Isat and Iunsat are the peak intensities with and without proton
saturation, respectively. Their uncertainties were determined from the root
mean-square noise in the background regions.
Data processing and structure calculations
Data were processed using NMRPipe (24) and analyzed with NMRView
(One Moon Scientiﬁc, Westﬁeld, NJ) (25) or Sparky (26). Because of the
repetitive nature of the designed amino acid sequence, the backbone spectral
assignments were done semimanually with the aid of the automatic spectral
assignment software packages AutoAssign (27) and MONTE (28,29).
Structure calculations were performed using CYANA v2.1 (30) based on
NOE restraints and Talos dihedral angle restraints from CSI (31). Hydrogen
bonding restraints were added for those residues that showed not only slow
exchange with water based on the small amide proton chemical shift de-
pendence on temperature (32), but also the helical 13C CSI as well as the
helical backbone NOE connectivities. To calculate the dimeric structures, the
restraints were duplicated for the two monomers, including 15 intermonomer
long-range NOEs observed in the 15N- or 13C-edited NOESY spectra. The
intermonomer NOEs were assigned by matching chemical shifts using an
exclusion strategy. A total of 100 structures were initially calculated by
CYANA. A bundle of 20 structures with the lowest target function is pre-
sented. Structures were analyzed using VMD (33) and Molmol (34).
The reduced spectral density mapping method (35) was used to qualita-
tively evaluate the dynamic characteristics of the protein. The reduced
spectral density functions at three frequencies, J(0), J(vN), and J(0.87vH),
were calculated from 15N R1, R2, and
15N-{1H} hetNOE by the following
matrix conversion (35):
where
1
B
¼ g
2
H
N 3 g2N3 h
2
43 r6NHN 3 4p
23
m0
4p
 
; (3)
and
1
F
¼ 3
B
1
D
23v2N
3
: (4)
The 15N-1H internuclear bond distance (rNH) of 1.02 A˚ and the
15N chemical
shift anisotropy (D) of –160 ppm were assumed in the calculation of the
matrix elements (35). General classiﬁcation of the spectral densities was
done by comparing the experimental spectral density values with the
theoretical curves for the single Lorentzian motion (36):
Jð0Þ3 JðvÞ ¼ Jð0Þ
2
11 5
2
3v3 Jð0Þ 2: (5)
Deviations from the single Lorentzian motion were used to determine
qualitatively whether there is an exchange contribution to the relaxation at
each residue. In addition, we also employed a similar qualitative method
proposed earlier (37) to use R1 3 R2 to effectively discriminate chemical
exchange contribution from the motional anisotropy contribution in the R2
relaxation. This method takes the advantage of the fact that the anisotropy
effects on correlation times are greatly attenuated in R13 R2 when vt 1.
After calculating the theoretical curve of R13 R2 as a function of R2/R1 using
the full spectral density expressions for R1 and R2, we compared the
experimental data with the theoretical curve in the R1 3 R2 dimension.
Any residues with excess R1 3 R2 values above the theoretical curve would
suggest a nonzero Rex term for those residues. To quantitatively analyze the
15N relaxation parameters and 15N-{1H} heteronuclear NOE, the model-free
approach (38–41) and the Modelfree program (41) were used. The model
selection was ﬁrst done based on the F-statistics in the R2/R1 diffusion
analysis. Because qualitative R1 3 R2 vs. R2/R1 analysis suggests that many
residues have nonzero Rex contribution in the R2 relaxation (see Results), the
global tumbling correlation time (tm) was determined by extensive search for
the tm value that gives the minimum reduced x
2 value and the least number
of nonﬁtted residues in the Modelfree data ﬁtting, instead of estimating from
the R2/R1 ratio.
RESULTS
Spectral assignments
As shown in Fig. 1, this designed protein has 14 Es, 12 Ks, 11
Ls, 9 As, 8 Gs, 2 Fs, 2 Ms, 2 Rs, and one C and W, with a
signiﬁcant amount of segment repetitiveness (e.g., 3 EEAAK
segments, 7 KL pairs, 6 EE pairs, etc.). Such sequence de-
generacy made the NMR spectral assignment difﬁcult. Fig. 2
shows a typical 1H-15N HSQC spectrum of (Aa2-L1M/
L38M)2. A total of 115 peaks can be found in this spectrum,
nearly twice as many as expected. It is clear that the peaks can
be classiﬁed into two sets based roughly on the intensities,
corresponding to two different conformations. From a suite
of triple-resonance NMR experiments, 61 out of the 62 res-
idues (except M1) for the major conformation could be
positively identiﬁed and assigned (see Supplementary Ma-
terial, Table S1). The ﬁnal assignments were marked in Fig.
2. Approximately 90% of the side-chain resonances in the
major conformation were assigned by using the 3D HCCH-
TOCSY. Because many peaks in the 3D spectra for the minor
conformation are too weak to be measured, only ;50% of
Jð0Þ
JðvNÞ
Jð0:87vHÞ
0
@
1
A ¼ 0:753F 1:53F 0:93FF 0 1:43F
0 0 0:23B
0
@
1
A3
R1
R2
gN3 ðNOE 1Þ3R1
gH
0
BB@
1
CCA; (2)
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reliable assignments for the second set of signals can be
made. Therefore, the current NMR data set does not allow a
complete structure and dynamics characterization of the
minor conformation. Possible sources of some of the minor
peaks include residual impurity in the protein preparation, a
very small population of the four-a-helix in the monomer
state, or different forms of dimers (e.g., parallel instead of
antiparallel dimers). In this study, we focus only on the major
conformation.
High-resolution structures of four-a-helix bundle
The sequential and midrange NOE connectivity in the major
conformation, the chemical shift indices (CSI), and the
temperature dependence of amide proton chemical shift are
summarized in Fig. 3. Similar to using line segments for
short- andmid-range NOEs, long-range NOEs (ji – jj. 4) are
also indicated by lines connecting the two interacting resi-
dues. Solid and dashed lines are used to distinguish the intra-
and inter-monomer long-range NOEs, respectively. Two
helical segments, from E7 to E27 and from E36 to R58, are
clearly discernible from the NOE connectivity. The Ca and
Cb CSI conﬁrms that at least the segments from E6 to K24
and from E36 to E57 are helical. The ﬁrst 5 residues from the
N-terminus, the last 5 residues to the C terminus, and 11
residues in the center from L25 to G35 have Ca and Cb
chemical shifts not signiﬁcantly different from the random-
coil values. The CSI data also suggest a certain degree of
disruption in the a-helicity near F52.
Fig. 4 A shows a bundle of 20 structures calculated using
the restraints derived from the NMR peaks in the major
conformation. The atomic coordinates of the structures have
been deposited in Protein Data Bank (PDB: 2I7U). The sta-
tistics of the structural calculation are given in Table 1. The
overall backbone RMSD, including the ﬂexible and less-
FIGURE 2 [1H, 15N]-HSQC of 13C/15N-labeled four-a-helix bundle in
90% H2O/10% D2O with a monomer concentration of 0.5 mM at 35C and
pH 4.5. Sixty-one of 62 backbone resonances of the major conformation are
assigned with the exception of M1. F12 is visible when the contour level is
lowered. On addition of anesthetics, these resonances become stronger,
which allows their assignments to be easily conﬁrmed in 3D experiments.
Assignments of the major conformation are labeled using the one-letter
amino acid code and the sequence number.
FIGURE 3 (A) Summary of NMR restraints determined for (Aa2-L1M/
L38M)2 four-a-helix bundle. Sequential and midrange NOE connectivity is
linked by the line segments, with the line thickness proportional to the
crosspeak intensity. For the long-range NOE [dij(ji–jj . 4)], the solid lines
represent intramonomer NOEs, and the dashed lines represent intermonomer
NOEs. The chemical shift index obtained from combining Ca and Cb shifts
is also shown. The amide proton chemical shift dependence on temperature
is marked under the sequence. Solid circle, solid star, and open circle
represent slow, medium, and fast exchange, respectively. (B) An example of
intersubunit NOESY assignment. Shown here are strip plots from 13C-edited
3D NOESY showing intersubunit NOE crosspeaks between G28 and L4.
Such crosspeaks cannot arise from the same subunit.
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structured terminal and linker regions, is 1.776 0.24 A˚. The
backbone RMSD for all four helical regions combined is
0.826 0.17 A˚. Further improvement of backbone RMSD by
residual dipole coupling (RDC) was not attempted because
high sequence redundancy and spectral overlap in the IPAP-
type spectra would not provide the needed accuracy in the
RDC frequency difference measurements.
Several features are readily apparent in the calculated
structures: 1), Because of the random-coil structures at the
two termini, the helical segments are somewhat shorter than
initially designed. 2), The dimer is antiparallel based on the
long-range NOEs between the two monomers (Fig. 3, dashed
lines). 3), There is a super-helical twist (coiled-coil) leading
to slight deformation of the helices (Fig. 4 B). 4), As origi-
nally designed, the ﬁrst helix from the N-terminus to the
linker (helix 1) is associated with the other ﬁrst helix (helix
19) in the dimer in an antiparallel fashion (likewise, helix 2
and helix 29 are associated with each other), such that the
hydrophobic surfaces composed of the a and d positions in
the helical heptad are facing each other in the hydrophobic
core. 5), The tertiary and quaternary arrangements of the four
helices are not completely symmetrical (Fig. 4 C). Helices
1 and 19 are closer to each other than helices 2 and 29. As will
be discussed later, this feature might be essential for creating
a lateral pathway for amphiphilic anesthetics to enter the
designed hydrophobic core.
Changes in chemical shifts of the amide protons at dif-
ferent temperatures are consistent with both the NOE con-
nectivity and the CSI result. As expected, the slope of
chemical shift change with temperature is small for residues
in the helical regions, indicating the existence of backbone
hydrogen bonding (32), whereas those with large chemical
shift changes with temperature are in the glycine linker re-
gion. Among the residues associated with the helices, those
whose chemical shifts are least sensitive to temperature tend
to be in the hydrophobic core of the protein. These data
further validate the spectral assignments and conﬁrm that the
four-a-helix bundle is a dimer with hydrophobic faces of the
monomers associating with each other to exclude the water in
the hydrophobic core.
Backbone dynamics
The R1, R2, and hetNOE data for the backbone amide
15N of
(Aa2-L1M/L38M)2, the reduced spectral density mapping
results, the R2/R1 ratio, and the graphical analyses of J(vN) as
a function J(0) and R13 R2 as a function of R2/R1 are shown
in Fig. 5. The dynamics in the two termini and the loop re-
gions are signiﬁcantly different from that in the helices. The
R1 values cluster in the 1.8–2.3 s
1 range throughout the
sequence, with only small variations in the loop region and
near the termini. In contrast, R2 and hetNOE values are sig-
niﬁcantly smaller in these regions (3.0–6.3 s1) than in the
helices (10.1–13.7 s1), suggesting considerable backbone
ﬂexibility in the loop and the termini. Two residues, M38 and
C41, have noticeably higher R2 values than their adjacent
residues (17.5 and 17.3 s1, respectively), indicating con-
siderable contributions from exchange in the R2 relaxation
for these residues. The hetNOE values are above 0.7 for all
residues in the a-helical regions. Initial estimates of the tm
value of the four-a-helix bundle, based on the R2/R1 ratio and
averaged over the residues in the a-helical regions, is 5.6 6
0.5 ns at 600 MHz. Because many residues have nonzero Rex
contributions to the R2 relaxation (see below). The tm value
should be determined independent of the R2/R1 ratio.
FIGURE 4 (A) The backbones of 20 lowest-energy structures of (Aa2-
L1M/L38M)2, ﬁtted from E6 to E27 and from E36 to E57. Two monomers
are colored gray and black for distinction. (B) Side view of (Aa2-L1M/
L38M)2 structure in ribbon representation, showing distortion in helix 2 and
helix 29. (C) Top view of (Aa2-L1M/L38M)2 structure in ribbon represen-
tation. Notice the overall asymmetry in the arrangement of the four helices.
The N-terminal helices are labeled as 1 and 19, and the C-terminal helices as
2 and 29.
TABLE 1 Statistics of 20 NMR structures with the lowest
target functions
NMR structure Statistic
Restraints per monomer
NOE distances
Intraresidue 168
Short range (ji–jj ¼ 1) 133
Medium range (1 , j i–jj # 4) 82
Long range (ji–jj . 4) 17
Dimer (intermonomer) 15
Dihedral angles 90
Hydrogen bonds 40
Residual upper limit constraint
violations . 0.5 A˚
0
Residual dihedral angle constraint
violations . 5
0
Backbone RMSD
Residues in helical regions only (6–27, 36–58) 0.82 6 0.17 A˚
All residues (1–62) 1.77 6 0.24 A˚
Heavy atom RMSD
Residues in helical regions only (6–27, 36–58) 1.38 6 0.20 A˚
All residues (1–62) 2.22 6 0.27 A˚
Ramachandran plot
Residues in most favored regions 92.8%
Residues in allowed regions 6.5%
Residues in disallowed regions 0.7%
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Qualitative analysis of the relaxation data using the re-
duced spectral density mapping method clearly indicates a
complex dynamics proﬁle of the dimeric (Aa2-L1M/L38M)2.
The points within the dashed ellipse in Fig. 5 H are those
from the loop and terminal residues, which are less structured
and highly ﬂexible. Many residues in the helices exhibit a
rightward shift from the theoretical single Lorentzian J(vN)
vs. J(0) curve, which is equivalent to the case of isotropic
tumbling in the model-free analysis. The rightward shift is an
indication that other motions, either anisotropic motion and/
or chemical and conformational exchange, contribute to the
R2 relaxation in addition to the global tumbling and internal
local motion. Since J(vN) is dominated by R1 and hetNOE
and is independent of Rex (see Eq. 2), the intersection be-
tween the single Lorentzian curve and the average J(vN)
values (horizontal line in Fig. 5 H) yields a J(0) value cor-
responding to an apparent correlation time should the protein
tumble isotropically. This estimate also gives a tm value of
;5.6 ns. To distinguish exchange from anisotropy contri-
butions, we compared experimental R1 3 R2 with the cor-
responding theoretical values (Fig. 5 I). If Rex ¼ 0, the
experimental R1 3 R2 would be smaller than the theoretical
values by a factor of S4, where S2 is the generalized order
parameter. A nonzero Rex would displace the experimental
values vertically by R1 3 Rex. As shown in Fig. 5 I, many
residues have nonzero Rex contributions to R2, with M38 and
C41 being distinctly different from the others. We conﬁrmed
the presence of exchange contribution to relaxation by the R2
dispersion measurements, in which the relaxation-compen-
sated, constant-time Carr-Purcell-Meiboom-Gill (CPMG)
sequences (42,43) were used to determine the R2 dependence
on the CPMG frequency. Detailed analyses of the relaxation
dispersion data and of the anesthetic effects on the confor-
mational exchange are discussed in Part II (22). Quantitative
analyses using the Lipari-Szabo model-free approach with
the NMR structure and the relaxation data as input are
depicted in Fig. 6. The model selection criteria based on
F-statistics suggested that the isotropic tumbling model ﬁt the
relaxation data of the apo protein better than the anisotropic
model. In agreement with the qualitative assessment, the
majority of residues in the helical region can be ﬁt best with
FIGURE 5 Dynamics analysis of the backbone amide 15N
of (Aa2-L1M/L38M)2 in H2O at 35C. Longitudinal and
transverse relaxation rate constants, R1 andR2, and
15N-{1H}
NOE values are shown in A, B, and C, respectively. The
reduced spectral density functions, J(0), J(vN), and
J(0.87vH), are shown in D, E, and F, respectively. R2/R1
ratio and the correlation between J(vN) and J(0) and between
R1 3 R2 and R2/R1 are shown in G, H, and I, respectively.
The relaxation data were acquired at 600MHz. Error bars are
either the standard errors in the least-squares ﬁt to the
exponential decay function (for R1 and R2) or the calculated
uncertainties (forNOE). (H) residues inside the dashedellipse
are from the loop region and the termini. The solid green
curves describe the dependence of J(vN) on J(0) in the
limiting case of single Lorentzian motion. Points to the right
of the green curve suggest the presence of exchange and/or
anisotropic contribution to the relaxation. (I) the contribution
of exchange and anisotropy can be effectively isolated
because the dependence of R1 3 R2 on correlation times is
greatly attenuated. Experimental data above the theoretical
curve (solid green curve) suggest the presence of Rex contri-
bution to the R2 relaxation.
FIGURE 6 Quantitative model-free analyses of the dynamics of (Aa2-
L1M/L38M)2 using Modelfree program: (A) the generalized squared-order
parameter (S2); (B) the local correlation time (te), (C) the exchange term
(Rex), and (D) the models used to ﬁt the data for each residue. Error bars are
standard errors from the ﬁtting.
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Model 3, which includes a nonzero Rex term indicative of
exchange contribution to the dynamics. Again, the most
noticeable dynamical hotspot is the large Rex term for resi-
dues M38 and C41, suggesting that the L38M mutation that
renders a 3.5-fold increase in halothane binding afﬁnity is at
an intrinsically dynamic site of the protein. Note also that the
entire loop region can be described only by Model 5, which
assumes internal backbone motions on multiple timescales.
Thus, the basic assumption for the model-free approach does
not strictly apply to the residues in the loop region. By
searching for the tm value that gives the minimum reduced x
2
value and the least number of nonﬁtted residues, Modelfree
calculations yielded a global tumbling time of 5.1 6 0.1 ns,
corresponding to a protein size of 11–12 kDa. Because the
(Aa2-L1M,L38M) monomer has a molecular mass of 6.86
kDa, the dynamics data conﬁrm that the major peaks used
for the model-free calculations indeed arise from the dimeric
form of the four-a-helix bundle.
DISCUSSION
We have solved the high-resolution structure of a designed
dimeric four-a-helix-bundle protein that was found previ-
ously to interact speciﬁcally with volatile anesthetics with
relatively high binding afﬁnities. Since the four-a-helix
bundle is a ubiquitous scaffold in functional proteins, our
designed protein is considered to be a suitable model for
anesthetic binding targets. The high and speciﬁc anesthetic
binding afﬁnity to (Aa2-L1M/L38M)2 suggests that certain
intrinsic structural and dynamical features of this particular
protein are essential for volatile anesthetic-protein interac-
tion. Our NMR structure and the dynamics data have re-
vealed some of these features that might be important for
anesthetic-protein interaction in general.
Spatial asymmetry of the four helices
An unexpected feature in the high-resolution structure is the
overall asymmetry in the spatial arrangement of the four
helices. Although the ﬁnal structures show a two-fold sym-
metry, which is consistent with the fact that the NMR peaks
in the helical region give a tumbling rate of a dimer and that
each peak arises from the same residue in the two monomers,
the quaternary arrangement of helices 1 and 19 is different
from that of helices 2 and 29, as shown in Fig. 4 C. Careful
examinations of the detailed side-chain packing of helices
1 and 19 shows a stack of aromatic rings from two F12 and
twoW15 residues in the hydrophobic core, as shown in Fig. 7A.
Moreover, there is excellent steric complementarity of eight
leucine residues (L4, L11, L18, and L25), all of which oc-
cupy the heptad e position at the interface of helices 1 and
19 (Fig. 7 A). The accumulation of van derWaals interactions,
in addition to the hydrophobic interactions, holds helices
1 and 19 together in an antiparallel fashion. In contrast, he-
lices 2 and 29 are wider apart from each other. The comple-
mentarity between the hydrophobic side chains of helices 2
and 29 is disrupted in the middle of the helical interface be-
cause K47 is at the heptad e position. The side chains of the
two K47 collide at nearly the same level (see Fig. 7). The
electrostatic repulsion of the charged side chains forces helix
2 to distort slightly. Deformation of helix 2 is also clearly
evident in the CSI result in Fig. 3.
Lateral accessibility to binding site
It is very likely that the two K47 in the middle of helix 2 play
an important role in the high-afﬁnity anesthetic binding in
this designed four-a-helix bundle. One of the most essen-
tial properties of general anesthetics is their tendency to
preferentially interact with amphipathic molecular targets
(4,44,45). As shown in Fig. 7, two K47 residues in the di-
meric (Aa2-L1M/L38M)2 are at the level midpoint to the two
W15 side chains. This creates an ideal amphipathic envi-
ronment. Most importantly, the opening in the middle of the
helices 2 and 29 interface creates a lateral access pathway for
anesthetics from the aqueous phase to enter the site between
the two W15 side chains in the center of the long hydro-
phobic core without passing through either end of the four
helix bundle. Thus, the predominant anesthetic binding site,
which has now been conﬁrmed experimentally (see Part II
(22)), is between the twoW15 aromatic side chains, bordered
additionally by A44 and A48 at the heptad a and e positions
at the same level. A closer examination of this particular
binding pocket also predicts that among the six L-to-A mu-
tations to convert (La2)2 to (Aa2)2 (18), the two L44A and
the two L48A are the most crucial ones responsible for the
increase in the halothane binding afﬁnity. The bulkier side
chains of leucine would require signiﬁcantly larger distortion
FIGURE 7 Side view (A) and top view (B) of the (Aa2-L1M/L38M)2
structure in ribbon representation, showing the relationship of important
side chains. Helices 1 and 19 are colored in yellow and helices 2 and 29 are
colored in purple. The complementary L4, L11, L18, and L25 are depicted in
gray in van der Waals spheres representation. F12, F52, W15, M38, and K47
are shown in licorice representation. F12 and F52 are shown in green, W15
in orange, M38 in red, and K47 in cyan.
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of helix 2 to accommodate a halothane molecule in this
pocket.
Importance of aromatic side chains
It is interesting to further analyze the orientations of aromatic
side chains from F12,W15, and F52 in the structure. All three
residues are located in the helical region. The intensities of
these residues in the HSQC spectrum are signiﬁcantly weaker
than other resonances in the major conformation, indicative
of intermediate conformational exchange. It is likely that, in
response to helix-2 global movement at the level of K47,
W15 side chains adapt different orientations in the hydro-
phobic core when the cavity between the two W15 side
chains is not occupied, as suggested previously by a ﬂuo-
rescence quenching study (21). This re-orientation of the
bulky W15 side chains will inevitably affect W15 backbone
dynamics. As we have found in the study with halothane (see
Part II (22)), the presence of a bound halothane stabilizes the
W15 side chains, resulting in not only halothane concentra-
tion-dependent shift of W15 backbone amide 1H and 15N
resonance, but also an increase in peak intensity for W15 in
the HSQC spectrum with halothane. The increases in peak
intensity after halothane binding strongly suggest that the
weak intensity of W15 in the absence of halothane is indeed
the result of intermediate conformation exchange.
In the NMR structure, F52 seems to be ‘‘out of place’’.
Although it is designed to be at the heptad g position, which is
supposed to be at the interface between helix 1 and helix 2 of
the same monomer, the F52 side chain is extended outward,
pointing into the aqueous phase. This is the direct conse-
quence of the helix 2 distortion from K47 to the C-terminus.
Having a highly hydrophobic side chain oriented into the
aqueous phase is energetically unfavorable. Hence, it is ex-
pected that the F52 side chain experiences a tremendous
amount of ﬂuctuations, which leads to greatly reduced F52
resonance in HSQC.
Because of its ‘‘odd’’ location, the F52 side chain can only
be stabilized by the ring stacking with the side chain of F12 in
the same monomer. This affords the possibility of another
two plausible anesthetic binding sites in (Aa2-L1M/L38M)2,
namely, the space sandwiched by the F12 and F52 side
chains. However, because of the extremely hydrophobic
rather than amphipathic nature of the phenylalanine residues,
these two additional anesthetic binding sites would be not as
favorable as the major binding site between the twoW15 side
chains.
Implications of dynamics in anesthetic binding
(Aa2-L1M/L38M)2 exhibits a very interesting motional
proﬁle as measured by the 15N backbone dynamics. As
shown in Fig. 6, our designed four-a-helix bundle is a very
dynamic protein in the absence of a bound anesthetic. Judged
by the nonzero Rex terms, it can be concluded that neither of
the two helices behave like a rigid rod. Instead, as discernible
in the NMR structure, the well known coiled-coil structural
twist commonly found in four-a-helix bundles might result
from the underlying superhelical twist motion. Indeed, when
we subject the NMR structure of (Aa2-L1M/L38M)2 to
normal mode analysis using ElNemo (46,47), we found that
the global mode (the ﬁrst nonzero mode) is dominated by a
large-amplitude winding and unwinding helical twist motion.
Such coiled-coil twist may prove to be the universal dynamic
characteristic of four-a-helix bundles. The fact that so many
structurally diverse anesthetics can interact with so many
proteins in a similar way suggests the possibility of an ‘‘in-
duced ﬁt’’ between small volatile anesthetic molecules and
their protein targets. The protein’s intrinsic ability to be
ﬂexible enough to accommodate necessary conformational
changes upon anesthetic binding is exempliﬁed in (Aa2-
L1M/L38M)2. It is tempting to speculate that the coupling
between the supercoil twisting global dynamics and the
structurally deﬁned amphipathic lateral pathway leading to
the binding pocket will facilitate the binding on-rate when the
binding site(s) are empty. As will be shown in the study with
anesthetics (see Part II (22)), the presence of halothane in the
binding site reduces the dynamics of (Aa2-L1M/L38M)2,
thus decreasing the off-rate of the bound halothane. Our
structural and dynamic data on the apo protein seem to sug-
gest the possibility of interplay between structural and global
dynamics as contributing factors for anesthetic-protein in-
teractions. This possibility is further explored in Part II (22).
In conclusion, to our knowledge, we have solved the ﬁrst
high-resolution structure of a designed anesthetic-binding
protein having the common four-a-helix bundle scaffold. In
the apo form, the protein is highly dynamic, with a clear
indication of conformational heterogeneity on the NMR
timescale. The major conformation is an antiparallel dimer
showing two helices from the N-terminus to the linker packed
neatly with a long stretch of eight complementary leucine
side chains at the heptad e positions and four aromatic rings
in the hydrophobic core. The two helices from the linker to
the C-terminus are less well packed because of two charged
K47 side chains being too close to each other. The distortion
of the second helix from a straight helix creates a lateral ac-
cess pathway for general anesthetics to reach the amphipathic
binding site between the two W15 side chains. The global
protein dynamics, coupled with the mobility near the ﬂexible
glycine linker, seems to contribute to the speciﬁc anesthetic
binding afﬁnity to this designed protein.
SUPPLEMENTARY MATERIAL
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